Recent studies have shown that MSCs can inhibit the activity of microglia around infarcted tissues and neuronal apoptosis through the CD200-CD200R pathway in stroke rats, thus exerting neuroprotective effects (17, 18). This evidence concerns the gene CD200R1 and stroke disorder.